UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	January 13, 2025

Accession Number:	0001140361-25-000685
Submission Type:	POS AM
CIK: 0001453687 Company Name: Cartesian Therapeutics, Inc. File Number: 333-281204